0.9504
3.27%
-0.0321
Rigel Pharmaceuticals (RIGL) 財務データ
損益計算書
四半期ごと
*すべての数値は百万単位です
期間終了日 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 |
期間の長さ | 3 か月 | 3 か月 | 3 か月 | 3 か月 | 3 か月 |
Revenues |
27.22%
35.79
|
28.13 | 26.89 | 26.07 | 51.28 |
Cost Of Revenue |
198.90%
3.79
|
1.268 | 1.075 | 0.977 | 0.342 |
Gross Profit |
19.12%
32.00
|
26.87 | 25.81 | 25.09 | 50.94 |
Operating Expenses
|
4.13%
30.04
|
31.33 | 31.08 | 37.82 | 48.86 |
Interest Income/Expense |
0.42%
1.907
|
1.899 | 1.862 | 1.204 | 1.107 |
Benefits Costs and Expenses |
7.53%
35.05
|
32.60 | 32.15 | 39.61 | 49.88 |
Costs And Expenses |
3.76%
33.83
|
32.60 | 32.15 | 38.80 | 49.20 |
Operating Income/Loss |
144.03%
1.966
|
-4.465 | -5.267 | -12.72 | 2.079 |
Income/Loss From Continuing Operations Before Tax |
116.51%
0.737
|
-4.465 | -6.60 | -13.54 | 1.401 |
Income/Loss From Continuing Operations After Tax |
112.95%
0.737
|
-5.692 | -6.60 | -13.54 | 1.401 |
Net Income/Loss
|
112.95%
0.737
|
-5.692 | -6.60 | -13.54 | 1.401 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
99.93%
0.12
|
174.36 | 173.75 | 173.57 | 0.15 |
Diluted Average Shares |
99.93%
0.12
|
174.36 | 173.75 | 173.57 | 0.15 |
Basic Earnings Per Share |
133.33%
0.010
|
-0.03 | -0.04 | -0.08 | 0.010 |
Diluted Earnings Per Share |
133.33%
0.010
|
-0.03 | -0.04 | -0.08 | 0.010 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
大文字化:
|
ボリューム (24 時間):